# Mechanism - Distance Threshold 0.6\n\nExperiment: threshold_0.6_mechanisms\nTotal clusters: 157\nSingleton clusters: 0 (0.0%)\nSilhouette score: 0.106\nDavies-Bouldin score: 0.497\n\n================================================================================\n\n## Cluster 0: cognitive training enhancement\n\n**Category**: neurocognitive modulation\n**Members**: 4\n\n- cognitive function improvement through multi-domain training\n- enhanced cognitive function through computerized training\n- enhanced cognitive function through gamified training\n- enhanced cognitive function through personalized training\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 8: urinary acidification via metabolic pathways\n\n**Category**: metabolic regulation\n**Members**: 3\n\n- decreased urinary pH through acid excretion\n- decreased urinary pH through increased acid load\n- decreased urinary pH through sulfur metabolism\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 17: Antibiotic treatment for H. pylori eradication\n\n**Category**: antimicrobial\n**Members**: 3\n\n- antibiotic treatment to eradicate H. pylori\n- antibiotic treatment to eradicate H. pylori in a sequential regimen\n- antibiotic treatment to eradicate H. pylori resistant to other antibiotics\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 1: GLP-1 Receptor Agonism\n\n**Category**: Metabolic Regulation\n**Members**: 2\n\n- activation of GLP-1 receptor\n- glucagon-like peptide-1 receptor agonist action\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 2: bone metabolism enhancement\n\n**Category**: metabolic regulation\n**Members**: 2\n\n- bone density increase\n- enhance bone metabolism and improve bone quality\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 6: Chloride Channel Activation\n\n**Category**: Gastrointestinal Motility\n**Members**: 2\n\n- activates chloride channels in the intestinal epithelium to increase fluid secretion\n- activates guanylate cyclase-C receptors to increase intestinal fluid secretion\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 9: bone turnover modulation\n\n**Category**: metabolic regulation\n**Members**: 2\n\n- accelerated bone turnover and bone loss\n- enhanced bone turnover and muscle function\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 11: Corticosteroid-mediated anti-inflammatory effects\n\n**Category**: anti-inflammatory\n**Members**: 2\n\n- anti-inflammatory effects through corticosteroid action\n- corticosteroid-mediated anti-inflammatory effects\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 12: Anti-estrogenic and anti-inflammatory effects\n\n**Category**: anti-inflammatory\n**Members**: 2\n\n- anti-estrogenic and anti-inflammatory properties\n- anti-inflammatory properties\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 13: social engagement enhancement\n\n**Category**: psychological modulation\n**Members**: 2\n\n- emotional engagement and social interaction\n- enhanced psychological and social engagement\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 14: cardiac function assessment during stress\n\n**Category**: physiological monitoring\n**Members**: 2\n\n- assessment of left ventricular function during stress\n- evaluation of myocardial blood flow during stress\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 15: Antibacterial action against Mycobacterium tuberculosis\n\n**Category**: antimicrobial\n**Members**: 2\n\n- antibacterial action against Mycobacterium tuberculosis\n- combined antibacterial action against Mycobacterium tuberculosis\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 18: Antibacterial action against H. pylori\n\n**Category**: antimicrobial\n**Members**: 2\n\n- antibacterial action against H. pylori\n- antimicrobial action against H. pylori\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 21: direct coagulation factor inhibition\n\n**Category**: anticoagulant\n**Members**: 2\n\n- direct factor Xa inhibition\n- direct thrombin inhibition\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 22: Behavioral modification and physical activity adherence\n\n**Category**: lifestyle intervention\n**Members**: 2\n\n- behavioral modification and increased physical activity adherence\n- behavioral modification and lifestyle changes\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 23: Antibiotic and bismuth therapy with probiotics for H. pylori eradication\n\n**Category**: antimicrobial\n**Members**: 2\n\n- antibiotic treatment and bismuth to eradicate H. pylori\n- antibiotic treatment and bismuth to eradicate H. pylori, supplemented with probiotics\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 24: Cognitive restructuring and behavioral modification\n\n**Category**: behavioral intervention\n**Members**: 2\n\n- behavioral change through cognitive restructuring\n- cognitive restructuring and behavioral modification\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 29: behavioral adherence enhancement\n\n**Category**: patient engagement strategies\n**Members**: 2\n\n- behavioral adherence improvement through education and follow-up\n- enhanced behavioral adherence and patient engagement\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 31: Anticoagulation to prevent thromboembolism\n\n**Category**: anti-thrombotic\n**Members**: 2\n\n- anticoagulation to prevent thromboembolic events\n- anticoagulation to prevent thrombus formation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 34: renal replacement therapy timing adjustment\n\n**Category**: therapeutic intervention\n**Members**: 2\n\n- delayed initiation of renal replacement therapy\n- early initiation of renal replacement therapy\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 38: Cell cycle arrest and apoptosis induction in tumor cells\n\n**Category**: apoptosis induction\n**Members**: 2\n\n- cell cycle arrest and apoptosis induction in tumor cells\n- cell cycle inhibition and apoptosis induction in tumor cells\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 44: 5-HT4 Receptor Activation\n\n**Category**: Neurotransmitter Modulation\n**Members**: 2\n\n- activates serotonin 5-hydroxytryptamine receptor 4 (5-HT4) to enhance gastrointestinal motility\n- activation of 5-HT4 receptors to enhance gastrointestinal motility\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 45: Cognitive enhancement via neural stimulation\n\n**Category**: Neurocognitive modulation\n**Members**: 2\n\n- cognitive stimulation and improved cognitive performance\n- enhanced cognitive engagement and neural stimulation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 39: dietary education sessions\n\n**Category**: nutritional education\n**Members**: 1\n\n- educational sessions on healthy diets\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 47: Pulmonary clot burden reduction\n\n**Category**: Thrombolytic\n**Members**: 1\n\n- direct reduction of pulmonary artery clot burden\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 48: Early cirrhosis detection and HCC surveillance\n\n**Category**: Disease surveillance\n**Members**: 1\n\n- early detection of cirrhosis and increased participation in HCC surveillance programmes\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 50: emotional stimulation and mood regulation\n\n**Category**: mental health\n**Members**: 1\n\n- emotional stimulation and mood regulation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 51: CDK4/6 Inhibition\n\n**Category**: cell cycle regulation\n**Members**: 1\n\n- cyclin-dependent kinase 4 and 6 inhibition\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 53: dietary behavior modification through feedback\n\n**Category**: behavioral intervention\n**Members**: 1\n\n- dietary behavior change support through meal logging and nutrient feedback\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 55: electrophysiological arrhythmia prevention\n\n**Category**: cardiovascular regulation\n**Members**: 1\n\n- electrophysiological modulation to prevent arrhythmias\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Remaining Clusters\n\nShowing top 30 of 100 total clusters. Remaining 70 clusters not shown (smaller clusters).\n\n